These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 22388763

  • 21. Increased likelihood of post-polycythemia vera myelofibrosis in Ph-negative MPN patients with chromosome 12 abnormalities.
    Benton CB, Tanaka M, Wilson C, Pierce S, Zhou L, Cortes J, Kantarjian H, Verstovsek S.
    Leuk Res; 2015 Apr; 39(4):419-23. PubMed ID: 25687833
    [Abstract] [Full Text] [Related]

  • 22. Genetic polymorphisms and expression of NLRP3 inflammasome-related genes are associated with Philadelphia chromosome-negative myeloproliferative neoplasms.
    Zhou Y, Yan S, Liu N, He N, Zhang A, Meng S, Ji C, Ma D, Ye J.
    Hum Immunol; 2020 Apr; 81(10-11):606-613. PubMed ID: 32981742
    [Abstract] [Full Text] [Related]

  • 23. MOLECULAR GENETIC ABNORMALITIES IN THE GENOME OF PATIENTS WITH Ph-NEGATIVE MYELOPROLIFERATIVE NEOPLASIA AFFECTED BY IONIZING RADIATION AS A RESULT OF THE CHORNOBYL NUCLEAR ACCIDENT.
    Poluben LO, Neumerzhytska LV, Klymenko SV, Fraenkel P, Balk C, Shumeiko OO.
    Probl Radiac Med Radiobiol; 2020 Dec; 25():362-373. PubMed ID: 33361847
    [Abstract] [Full Text] [Related]

  • 24. Flow cytometry immunophenotypic analysis of Philadelphia-negative myeloproliferative neoplasms: Correlation with histopathologic features.
    Ouyang J, Zheng W, Shen Q, Goswami M, Jorgensen JL, Medeiros LJ, Wang SA.
    Cytometry B Clin Cytom; 2015 Dec; 88(4):236-43. PubMed ID: 25557358
    [Abstract] [Full Text] [Related]

  • 25. JAK2-positive cutaneous myelofibrosis presenting as sclerosing extramedullary hematopoietic tumors on the scalp: case presentation and review of the literature.
    LeBlanc RE, Lester L, Kwong B, Rieger KE.
    J Cutan Pathol; 2015 Nov; 42(11):858-62. PubMed ID: 26153565
    [Abstract] [Full Text] [Related]

  • 26. Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project.
    Mora B, Giorgino T, Guglielmelli P, Rumi E, Maffioli M, Rambaldi A, Caramella M, Komrokji R, Gotlib J, Kiladjian JJ, Cervantes F, Devos T, Palandri F, De Stefano V, Ruggeri M, Silver RT, Benevolo G, Albano F, Cavalloni C, Barraco D, Merli M, Pietra D, Casalone R, Barbui T, Rotunno G, Cazzola M, Vannucchi AM, Passamonti F.
    Haematologica; 2018 Sep; 103(9):e392-e394. PubMed ID: 29622658
    [No Abstract] [Full Text] [Related]

  • 27. B-mode ultrasound and contrast-enhanced ultrasound pattern of focal extramedullary hematopoiesis of the spleen in a patient with myeloproliferative disease.
    Huynh MQ, Barth P, Sohlbach K, Neubauer A, Görg C.
    Ultraschall Med; 2009 Jun; 30(3):297-9. PubMed ID: 19253208
    [No Abstract] [Full Text] [Related]

  • 28. Reproducibility of the WHO histological criteria for the diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasms.
    Gianelli U, Bossi A, Cortinovis I, Sabattini E, Tripodo C, Boveri E, Moro A, Valli R, Ponzoni M, M Florena A, F Orcioni G, Ascani S, Bonoldi E, Iurlo A, Gugliotta L, Franco V.
    Mod Pathol; 2014 Jun; 27(6):814-22. PubMed ID: 24201120
    [Abstract] [Full Text] [Related]

  • 29. [Histological diagnosis of Ph-negative myeloproliferative neoplasia. An overview].
    Campr V.
    Cesk Patol; 2011 Jul; 47(3):84-93. PubMed ID: 21887923
    [Abstract] [Full Text] [Related]

  • 30. Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms.
    Rumi E, Cazzola M.
    Blood; 2017 Feb 09; 129(6):680-692. PubMed ID: 28028026
    [Abstract] [Full Text] [Related]

  • 31. Interesting splenic histology in a patient with advanced myelofibrosis.
    Chandler I, DeLord C.
    Br J Haematol; 2002 Jul 09; 118(1):1. PubMed ID: 12100123
    [No Abstract] [Full Text] [Related]

  • 32. JAK2-V617F-mutated myeloproliferative neoplasms reveal different allele burden within hematopoietic cell lineages: a microdissection study of bone marrow trephine biopsies.
    Kreft A, Kindler T, Springer E, Kirkpatrick CJ.
    Virchows Arch; 2011 Nov 09; 459(5):521-7. PubMed ID: 22006129
    [Abstract] [Full Text] [Related]

  • 33. JAK2-positive Philadelphia-negative myeloproliferative neoplasms.
    Sharma A, Buxi G, Marwah S, Yadav R.
    Indian J Pathol Microbiol; 2011 Nov 09; 54(1):117-20. PubMed ID: 21393891
    [Abstract] [Full Text] [Related]

  • 34. Myelofibrosis presenting as splenic tumor.
    Macumber C, Phan TG, Young GA, Selby WS.
    Dig Dis Sci; 1999 Sep 09; 44(9):1817-22. PubMed ID: 10505720
    [No Abstract] [Full Text] [Related]

  • 35. GATA1 downregulation in prefibrotic and fibrotic stages of primary myelofibrosis and in the myelofibrotic progression of other myeloproliferative neoplasms.
    Sangiorgio VFI, Nam A, Chen Z, Orazi A, Tam W.
    Leuk Res; 2021 Jan 09; 100():106495. PubMed ID: 33360878
    [Abstract] [Full Text] [Related]

  • 36. Sclerosing extramedullary hematopoietic tumor.
    Yang X, Bhuiya T, Esposito M.
    Ann Diagn Pathol; 2002 Jun 09; 6(3):183-7. PubMed ID: 12089730
    [Abstract] [Full Text] [Related]

  • 37. Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis.
    Rambaldi B, Diral E, Donsante S, Di Marzo N, Mottadelli F, Cardinale L, Dander E, Isimbaldi G, Pioltelli P, Biondi A, Riminucci M, D'Amico G, Elli EM, Pievani A, Serafini M.
    Ann Hematol; 2021 Jan 09; 100(1):105-116. PubMed ID: 33089365
    [Abstract] [Full Text] [Related]

  • 38. Abnormal myelopoietic clones in man.
    McCulloch EA.
    J Natl Cancer Inst; 1979 Oct 09; 63(4):883-92. PubMed ID: 384008
    [No Abstract] [Full Text] [Related]

  • 39. Clinical Manifestations and Risk Factors for Complications of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
    Duangnapasatit B, Rattarittamrong E, Rattanathammethee T, Hantrakool S, Chai-Adisaksopha C, Tantiworawit A, Norasetthada L.
    Asian Pac J Cancer Prev; 2015 Oct 09; 16(12):5013-8. PubMed ID: 26163633
    [Abstract] [Full Text] [Related]

  • 40. Jak-2 positive myeloproliferative neoplasms.
    Muxí PJ, Oliver AC.
    Curr Treat Options Oncol; 2014 Jun 09; 15(2):147-56. PubMed ID: 24627006
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.